Overview

Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the efficacy, safety and tolerability of NGX 4010 applied for 60 minutes for the treatment of PHN.
Phase:
Phase 3
Details
Lead Sponsor:
NeurogesX
Treatments:
Capsaicin